Jeff D. Thostenson

1.7k total citations
36 papers, 1.3k citations indexed

About

Jeff D. Thostenson is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Jeff D. Thostenson has authored 36 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 11 papers in Epidemiology and 10 papers in Oncology. Recurrent topics in Jeff D. Thostenson's work include Bone Metabolism and Diseases (14 papers), Bone health and treatments (10 papers) and Bone health and osteoporosis research (5 papers). Jeff D. Thostenson is often cited by papers focused on Bone Metabolism and Diseases (14 papers), Bone health and treatments (10 papers) and Bone health and osteoporosis research (5 papers). Jeff D. Thostenson collaborates with scholars based in United States, Australia and Norway. Jeff D. Thostenson's co-authors include Charles A. O’Brien, Jinhu Xiong, M. Piemontese, Maria Almeida, Stavros C. Manolagas, Melda Onal, Yuko Fujiwara, Robert S. Weinstein, Alan J. Budney and John R. Hughes and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and The Journal of Physiology.

In The Last Decade

Jeff D. Thostenson

30 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeff D. Thostenson United States 15 774 408 300 158 143 36 1.3k
Donna Montague United States 9 637 0.8× 319 0.8× 213 0.7× 51 0.3× 66 0.5× 12 1.1k
Fanglin Guan China 23 544 0.7× 102 0.3× 125 0.4× 79 0.5× 246 1.7× 47 1.2k
Kenichi Inagaki Japan 27 816 1.1× 170 0.4× 101 0.3× 46 0.3× 212 1.5× 74 1.7k
Akiko Iida‐Klein United States 21 1.1k 1.4× 624 1.5× 329 1.1× 35 0.2× 151 1.1× 31 1.6k
Michael De Lisio Canada 25 845 1.1× 155 0.4× 246 0.8× 21 0.1× 139 1.0× 84 2.0k
Marco Faustini‐Fustini Italy 23 450 0.6× 188 0.5× 257 0.9× 37 0.2× 722 5.0× 45 2.2k
Heléne Fischer Sweden 22 782 1.0× 234 0.6× 85 0.3× 27 0.2× 198 1.4× 38 1.5k
Nico Lakenberg Netherlands 18 443 0.6× 134 0.3× 37 0.1× 163 1.0× 187 1.3× 47 1.2k
Garry A Williams New Zealand 8 309 0.4× 85 0.2× 172 0.6× 32 0.2× 30 0.2× 11 763
Tetsuya Yoda Japan 17 349 0.5× 97 0.2× 64 0.2× 36 0.2× 60 0.4× 53 795

Countries citing papers authored by Jeff D. Thostenson

Since Specialization
Citations

This map shows the geographic impact of Jeff D. Thostenson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeff D. Thostenson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeff D. Thostenson more than expected).

Fields of papers citing papers by Jeff D. Thostenson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeff D. Thostenson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeff D. Thostenson. The network helps show where Jeff D. Thostenson may publish in the future.

Co-authorship network of co-authors of Jeff D. Thostenson

This figure shows the co-authorship network connecting the top 25 collaborators of Jeff D. Thostenson. A scholar is included among the top collaborators of Jeff D. Thostenson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeff D. Thostenson. Jeff D. Thostenson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maraka, Spyridoula, Richard R. Owen, Naykky Singh Ospina, et al.. (2025). Discontinuation of levothyroxine therapy in patients with subclinical hypothyroidism: a pilot randomized clinical trial. Endocrine. 90(2). 781–792.
2.
Palmieri, Michela, Spyridoula Maraka, Horace J. Spencer, et al.. (2025). Plasma levels of anti phosphocholine IgM antibodies are negatively correlated with bone mineral density in humans. Scientific Reports. 15(1). 2109–2109.
3.
4.
Toloza, Freddy J.K., Richard R. Owen, James S. Williams, et al.. (2024). Frequency and Determinants of Levothyroxine Therapy Initiation for Veterans with Subclinical Hypothyroidism. Journal of Clinical Medicine. 13(19). 5727–5727. 2 indexed citations
5.
Richardson, Kimberly, Gareeballah Osman Adam, Wen Ling, et al.. (2024). Mitochondrial protein deacetylation by SIRT3 in osteoclasts promotes bone resorption with aging in female mice. Molecular Metabolism. 88. 102012–102012. 6 indexed citations
6.
Toloza, Freddy J.K., Horace J. Spencer, Jeff D. Thostenson, et al.. (2024). A Predictive Model for Graves’ Disease Recurrence After Antithyroid Drug Therapy: A Retrospective Multicenter Cohort Study. Endocrine Practice. 31(4). 455–464. 1 indexed citations
7.
Fu, Qiang, Igor Gubrij, Jeff D. Thostenson, et al.. (2023). Reduced osteoprotegerin expression by osteocytes may contribute to rebound resorption after denosumab discontinuation. JCI Insight. 8(18). 31 indexed citations
8.
Akel, Nisreen, Julie Crawford, Qiang Fu, et al.. (2023). CRISPR interference provides increased cell type-specificity compared to the Cre-loxP system. iScience. 26(8). 107428–107428. 4 indexed citations
9.
Mears, Simon C., Jeff D. Thostenson, Erin M. Mannen, et al.. (2022). Inter-Rater Reliability of Clinical Testing for Laxity After Knee Arthroplasty. The Journal of Arthroplasty. 37(7). 1296–1301. 4 indexed citations
10.
Kim, Ha‐Neui, Jinhu Xiong, Srividhya Iyer, et al.. (2020). Osteocyte RANKL is required for cortical bone loss with age and is induced by senescence. JCI Insight. 5(19). 75 indexed citations
11.
Xiong, Jinhu, Igor Gubrij, Yu Liu, et al.. (2020). Local Production of Osteoprotegerin by Osteoblasts Suppresses Bone Resorption. Cell Reports. 32(10). 108052–108052. 79 indexed citations
12.
Zimmerman, Sarah M., et al.. (2018). Loss of RANKL in osteocytes dramatically increases cancellous bone mass in the osteogenesis imperfecta mouse (oim). Bone Reports. 9. 61–73. 32 indexed citations
13.
Fujiwara, Yuko, M. Piemontese, Yu Liu, et al.. (2016). RANKL (Receptor Activator of NFκB Ligand) Produced by Osteocytes Is Required for the Increase in B Cells and Bone Loss Caused by Estrogen Deficiency in Mice. Journal of Biological Chemistry. 291(48). 24838–24850. 77 indexed citations
14.
Piemontese, M., Melda Onal, Jinhu Xiong, et al.. (2016). Low bone mass and changes in the osteocyte network in mice lacking autophagy in the osteoblast lineage. Scientific Reports. 6(1). 24262–24262. 85 indexed citations
15.
Piemontese, M., Melda Onal, Jinhu Xiong, et al.. (2015). Suppression of autophagy in osteocytes does not modify the adverse effects of glucocorticoids on cortical bone. Bone. 75. 18–26. 46 indexed citations
16.
Xiong, Jinhu, M. Piemontese, Jeff D. Thostenson, et al.. (2014). Osteocyte-derived RANKL is a critical mediator of the increased bone resorption caused by dietary calcium deficiency. Bone. 66. 146–154. 91 indexed citations
17.
JOHNSON, JEFF, Jeff D. Thostenson, Larry J. Suva, & S. Ashfaq Hasan. (2013). Relationship of Bicipital Groove Rotation with Humeral Head Retroversion. Journal of Bone and Joint Surgery. 95(8). 719–724. 21 indexed citations
18.
Onal, Melda, Jinhu Xiong, Xinrong Chen, et al.. (2012). Receptor Activator of Nuclear Factor κB Ligand (RANKL) Protein Expression by B Lymphocytes Contributes to Ovariectomy-induced Bone Loss. Journal of Biological Chemistry. 287(35). 29851–29860. 182 indexed citations
19.
Budney, Alan J., Ryan G. Vandrey, John R. Hughes, Jeff D. Thostenson, & Zoran Bursac. (2008). Comparison of cannabis and tobacco withdrawal: Severity and contribution to relapse. Journal of Substance Abuse Treatment. 35(4). 362–368. 138 indexed citations
20.
Thostenson, Jeff D., et al.. (2007). Weight effect of saline accumulation in surgical drapes. Canadian Journal of Ophthalmology. 42(5). 695–697.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Donna Montague Breakdown of academic impact, for papers by Fanglin Guan Breakdown of academic impact, for papers by Kenichi Inagaki Breakdown of academic impact, for papers by Akiko Iida‐Klein Breakdown of academic impact, for papers by Michael De Lisio Breakdown of academic impact, for papers by Marco Faustini‐Fustini Breakdown of academic impact, for papers by Heléne Fischer Breakdown of academic impact, for papers by Nico Lakenberg Breakdown of academic impact, for papers by Garry A Williams Breakdown of academic impact, for papers by Tetsuya Yoda
Rankless by CCL
2026